Out-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With Cancer

TitleOut-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With Cancer
Publication TypeJournal Article
Year of Publication2017
AuthorsNarang, AK, Nicholas, LHersch
JournalJAMA Oncology
Volume3
Issue6
Pagination757-765
Date Published06/2017
ISSN Number2374-2437
KeywordsFinancial burden, Medicare/Medicaid/Health Insurance, Older Adults, OOPM
Abstract

IMPORTANCE:
Medicare beneficiaries with cancer are at risk for financial hardship given increasingly expensive cancer care and significant cost sharing by beneficiaries.

OBJECTIVES:
To measure out-of-pocket (OOP) costs incurred by Medicare beneficiaries with cancer and identify which factors and services contribute to high OOP costs.

DESIGN, SETTING, AND PARTICIPANTS:
We prospectively collected survey data from 18 166 community-dwelling Medicare beneficiaries, including 1409 individuals who were diagnosed with cancer during the study period, who participated in the January 1, 2002, to December 31, 2012, waves of the Health and Retirement Study, a nationally representative panel study of US residents older than 50 years. Data analysis was performed from July 1, 2014, to June 30, 2015.

MAIN OUTCOMES AND MEASURES:
Out-of-pocket medical spending and financial burden (OOP expenditures divided by total household income).

RESULTS:
Among the 1409 participants (median age, 73 years [interquartile range, 69-79 years]; 46.4% female and 53.6% male) diagnosed with cancer during the study period, the type of supplementary insurance was significantly associated with mean annual OOP costs incurred after a cancer diagnosis ($2116 among those insured by Medicaid, $2367 among those insured by the Veterans Health Administration, $5976 among those insured by a Medicare health maintenance organization, $5492 among those with employer-sponsored insurance, $5670 among those with Medigap insurance coverage, and $8115 among those insured by traditional fee-for-service Medicare but without supplemental insurance coverage). A new diagnosis of cancer or common chronic noncancer condition was associated with increased odds of incurring costs in the highest decile of OOP expenditures (cancer: adjusted odds ratio, 1.86; 95% CI, 1.55-2.23; P < .001; chronic noncancer condition: adjusted odds ratio, 1.82; 95% CI, 1.69-1.97; P < .001). Beneficiaries with a new cancer diagnosis and Medicare alone incurred OOP expenditures that were a mean of 23.7% of their household income; 10% of these beneficiaries incurred OOP expenditures that were 63.1% of their household income. Among the 10% of beneficiaries with cancer who incurred the highest OOP costs, hospitalization contributed to 41.6% of total OOP costs.

CONCLUSIONS AND RELEVANCE:
Medicare beneficiaries without supplemental insurance incur significant OOP costs following a diagnosis of cancer. Costs associated with hospitalization may be a primary contributor to these high OOP costs. Medicare reform proposals that restructure the benefit design for hospital-based services and incorporate an OOP maximum may help alleviate financial burden, as can interventions that reduce hospitalization in this population.

URLhttp://oncology.jamanetwork.com/article.aspx?doi=10.1001/jamaoncol.2016.4865
DOI10.1001/jamaoncol.2016.4865
Short TitleJAMA Oncol
Citation Key8814
PubMed ID27893028
PubMed Central IDPMC5441971